KEYS vs PLRX · P/E 57, rev $4.98B vs $77.3M cap
Keysight Technologies Inc (KEYS) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the KEYS and PLRX stock pages for the full models.
Not investment advice.